Insider at

04

Insider transactions

05
0 buys (P) 0 sells (S) Net: $0 + 19 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

19 other filings hidden
DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
June 18, 2024 CBIO P 17,500 $0.25 $4,375 70,643 Direct +32.93% Acquired -42.7% (price as of 2026-10-02)
May 17, 2023 CBIO S 3,700 $1.95 $7,215 53,143 Direct -6.51% Disposed -92.7% (price as of 2026-10-02)
Nov. 11, 2022 CBIO P 20,000 $1.06 $21,200 56,843 Direct +54.28% Acquired -86.5% (price as of 2026-10-02)
March 9, 2022 CBIO S 2,917 $1.09 $3,180 36,843 Direct -7.34% Disposed -86.9% (price as of 2026-10-02)
June 11, 2018 CBIO S 19,345 $18.04 $348,984 0 Direct -100.00% Disposed -99.2% (price as of 2026-10-02)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
Jan. 12, 2024 CBIO Employee Stock Option (right to buy) Common Stock (250,000) $3.11 Jan. 11, 2034 250,000 Acquired
Jan. 19, 2023 CBIO Employee Stock Option (right to buy) Common Stock (246,300) $2.55 Jan. 18, 2033 246,300 Acquired
Jan. 21, 2022 CBIO Employee Stock Option (right to buy) Common Stock (47,700) $1.11 Jan. 20, 2032 47,700 Acquired
Jan. 21, 2022 CBIO Employee Stock Option (right to buy) Common Stock (164,700) $1.11 Jan. 20, 2032 164,700 Acquired
Jan. 20, 2021 CBIO Employee Stock Option (right to buy) Common Stock (69,000) $3.81 Jan. 19, 2031 69,000 Acquired
Dec. 16, 2020 CBIO Employee Stock Option (right to buy) Common Stock (5,260) $1.12 Jan. 4, 2021 5,260 Disposed
Jan. 22, 2020 CBIO Employee Stock Option (right to buy) Common Stock (120,000) $4.72 Jan. 21, 2030 120,000 Acquired
Jan. 17, 2019 CBIO Employee Stock Option (right to buy) Common Stock (90,000) $10.59 Jan. 16, 2029 90,000 Acquired
June 11, 2018 CBIO Employee Stock Option (right to buy) Common Stock (5,260) $1.12 Jan. 4, 2021 5,260 Disposed
Jan. 10, 2018 CBIO Employee Stock Option (right to buy) Common Stock (65,000) $20.03 Jan. 9, 2028 65,000 Acquired
Jan. 4, 2017 CBIO Employee Stock Option (right to buy) Common Stock (65,000) $6.33 Jan. 3, 2027 65,000 Acquired
Jan. 7, 2016 CBIO Employee Stock Option (right to buy) Common Stock (65,000) $5.22 Jan. 6, 2026 65,000 Acquired
Feb. 27, 2015 CBIO Employee Stock Option (right to buy) Common Stock (5,000) $1.12 Jan. 4, 2021 5,000 Disposed
Jan. 8, 2015 CBIO Employee Stock Option (right to buy) Common Stock (61,000) $7.15 Jan. 7, 2025 61,000 Acquired
Jan. 9, 2014 CBIO Stock Option (right to buy) Common Stock (37,564) $8.00 Jan. 9, 2024 37,564 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 3 holdings

07

Securities held when first becoming an insider, per SEC Form 3.

DateTickerSecuritySharesOwnership
Jan. 9, 2014 CBIO Common Stock 9,085 Direct
Jan. 9, 2014 CBIO Employee Stock Option (right to buy)→ Common Stock · Direct
Jan. 9, 2014 CBIO Employee Stock Option (right to buy)→ Common Stock · Direct

Compensation (DEF 14A)

08

Matched by name from proxy statements (DEF 14A) — verify against the filing.

Fiscal yearSalaryBonusStock awards Option awardsNon-equity incentivePension changeOtherTotal
2014 $285,387 · · · $75,075 · · $590,729

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.